Table 2. The disease progression pattern in ESCC treated by definitive CCRT.

First disease progression site	n (%)
No disease progression	35 (28.2)
Distant failure only
Distant site	32 (25.8)
Locoregional failure only
Esophagus	22 (17.7)
Esophagus + Regional LN〒	14 (11.3)
Regional LN	9 (7.3)
Both locoregional and distant failure
Regional LN + Distant site	7 (5.6)
Esophagus + Distant site	3 (2.4)
Esophagus + Regional LN + Distant site	2 (1.6)

^〒LN: lymph nodes